iSpecimen Inc. (ISPC)Healthcare | Diagnostics & Research | Woburn, United States | NasdaqCM
1.54 USD
-0.06
(-3.750%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.53 -0.01 (-0.008%) ⇩ (Aug. 28, 2026, 7:56 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 4:22 a.m. EDT
The immediate catalyst driving the stock's recent surge is a classic micro-cap manipulation setup: a massive 1-for-40 reverse split combined with a drastic reduction in share count, creating an artificial scarcity of shares on the open market. This 'low-float' dynamic has attracted speculative traders pushing the price higher, but it masks a catastrophic underlying reality. Fundamentally, the business is in freefall, having lost over 99% of its value over the last four years with zero positive annual returns during that entire period. The company is hemorrhaging cash, reporting negative revenue growth, and burning through operating capital while posting massive losses on both the income statement and balance sheet. With no dividends paid and a negative forward earnings estimate, there is no safety net for investors. While the technicals show a sharp, short-term pop due to the reverse split hype, the long-term outlook remains dire as the core business continues to deteriorate without any signs of recovery. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.079673 |
| AutoARIMA | 0.224345 |
| AutoETS | 0.224347 |
| MSTL | 0.230827 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 14.76 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.229 |
| Excess Kurtosis | 0.10 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 13.874 |
| Revenue per Share | 0.896 |
| Market Cap | 3,878,628 |
| Forward P/E | -1.95 |
| Beta | 1.64 |
| Website | https://ispecimen.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.94358253 |
| Address1 | 8 Cabot Road |
| Address2 | Suite 1800 |
| All Time High | 23,184.0 |
| All Time Low | 1.4 |
| Ask | 1.95 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 1,016,330 |
| Average Daily Volume3 Month | 242,208 |
| Average Volume | 242,208 |
| Average Volume10Days | 1,016,330 |
| Beta | 1.635 |
| Bid | 1.15 |
| Bid Size | 2 |
| Book Value | 14.57 |
| City | Woburn |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.54 |
| Current Ratio | 0.819 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.6081 |
| Day Low | 1.51 |
| Debt To Equity | 13.874 |
| Display Name | iSpecimen |
| Earnings Call Timestamp End | 1,722,947,400 |
| Earnings Call Timestamp Start | 1,722,947,400 |
| Earnings Timestamp End | 1,747,684,800 |
| Earnings Timestamp Start | 1,747,684,800 |
| Ebitda | -9,284,936 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.032 |
| Enterprise To Revenue | -0.632 |
| Enterprise Value | -294,832 |
| Eps Forward | -0.79 |
| Eps Trailing Twelve Months | -48.9 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.2426 |
| Fifty Day Average Change | -0.7026 |
| Fifty Day Average Change Percent | -0.31329706 |
| Fifty Two Week Change Percent | -94.35825 |
| Fifty Two Week High | 127.2 |
| Fifty Two Week High Change | -125.659996 |
| Fifty Two Week High Change Percent | -0.98789304 |
| Fifty Two Week Low | 1.4 |
| Fifty Two Week Low Change | 0.13999999 |
| Fifty Two Week Low Change Percent | 0.099999994 |
| Fifty Two Week Range | 1.4 - 127.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,623,936,600,000 |
| Float Shares | 2,518,590 |
| Forward Eps | -0.79 |
| Forward P E | -1.949367 |
| Free Cashflow | -5,581,286 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 7 |
| Fullday Change | -0.0600001 |
| Fullday Change Percent | -3.75 |
| Fullday Price | 1.5317 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -1.08262 |
| Gross Profits | -504,830 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00042 |
| Held Percent Institutions | 0.025799999 |
| Implied Shares Outstanding | 2,518,590 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Ipo Expected Date | 2,021-06-17 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,777,334,400 |
| Last Split Factor | 1:40 |
| Long Business Summary | iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts. |
| Long Name | iSpecimen Inc. |
| Market | us_market |
| Market Cap | 3,878,628 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_217734917 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -11,419,925 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,029,744 |
| Open | 1.6 |
| Operating Cashflow | -7,004,000 |
| Operating Margins | -8.97055 |
| Payout Ratio | 0.0 |
| Phone | 781 301 6700 |
| Post Market Change | -0.008299947 |
| Post Market Change Percent | -0.5389576 |
| Post Market Price | 1.5317 |
| Post Market Time | 1,787,961,393 |
| Previous Close | 1.6 |
| Price Hint | 4 |
| Price To Book | 0.10569663 |
| Price To Sales Trailing12 Months | 8.317845 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.81 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0600001 |
| Regular Market Change Percent | -3.75 |
| Regular Market Day High | 1.6081 |
| Regular Market Day Low | 1.51 |
| Regular Market Day Range | 1.51 - 1.6081 |
| Regular Market Open | 1.6 |
| Regular Market Previous Close | 1.6 |
| Regular Market Price | 1.54 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 87,851 |
| Return On Assets | -0.87687 |
| Return On Equity | -9.6846695 |
| Revenue Growth | -0.787 |
| Revenue Per Share | 0.896 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,518,590 |
| Shares Percent Shares Out | 0.0594 |
| Shares Short | 149,705 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 184,505 |
| Short Name | iSpecimen Inc. |
| Short Percent Of Float | 0.0594 |
| Short Ratio | 1.52 |
| Source Interval | 15 |
| State | MA |
| Symbol | ISPC |
| Total Cash | 4,414,364 |
| Total Cash Per Share | 1.753 |
| Total Debt | 240,903 |
| Total Revenue | 466,302 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -48.9 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.4732 |
| Two Hundred Day Average Change | -6.9332 |
| Two Hundred Day Average Change Percent | -0.8182505 |
| Type Disp | Equity |
| Volume | 87,851 |
| Website | https://ispecimen.com |
| Zip | 1,801 |